ASİMPLEX 250 MG LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION

ASİMPLEX 250 MG LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION
Product Description

Herpes simplex infections in immunosuppressed patients: ASİMPLEX is indicated for the treatment of initial and recurrent cutaneous and mucosal herpes simplex (HSV1 and HSV2) in immunocompromised individuals and immunosuppressed patients. In initial infection of genital herpes: ASİMPLEX is indicated for the treatment of severe initial genital herpes in the non-immunocompromised patients. Herpes simplex encephalitis: ASİMPLEX is indicated for the treatment of Herpes simplex encephalitis. Neonatal Herpes simplex virus infection: ASİMPLEX is indicated for the treatment of neonatal herpes infections. Varicella zoster infections in immunosuppressed patients: ASİMPLEX is indicated for the treatment of Herpes zoster(zona) infections in immunocompromised individuals and immunosuppressed patients. 

Polifarma Ilac San. ve Tic. A.S.

  • TR
  • 2015
    On CPhI since
  • 4
    Certificates
  • 1000 - 4999
    Employees
Other
Specifications
  • CAS Registry Number
    3
  • Supplied from
    Turkey

Polifarma Ilac San. ve Tic. A.S.

  • TR
  • 2015
    On CPhI since
  • 4
    Certificates
  • 1000 - 4999
    Employees
Other

More Products from Polifarma Ilac San. ve Tic. A.S.

Polifarma Ilac San. ve Tic. A.S. resources

Recommended products